Physician profile
Brian C Kindred
NPI 1366435778
$18,482.51
in general payments reported to CMS, 2019-2025
13 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,271 · 2020: $10K · 2021: $4,771 · 2022: $178 · 2023: $125 · 2024: $314 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,314 · Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,313.53 |
| Food and Beverage | $566.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $15,925.56 | 2019-2022 | |
| Restor3d, INC. | $1,449.25 | 2024-2025 | |
| Catalyst Orthoscience | $307.79 | 2021 | |
| Depuy Synthes Sales INC. | $203.97 | 2019-2024 | Orthovisc, Peak, Monovisc |
| Zimmer Biomet Holdings, INC. | $147.73 | 2019 | |
| Medacta USA, INC. | $91.20 | 2024 | |
| Ferring Pharmaceuticals INC. | $87.69 | 2022-2024 | Euflexxa |
| Stryker Corporation | $72.19 | 2024 | Variax |
| Maxx Orthopedics, INC. | $70.15 | 2023 | |
| Smith+Nephew, INC. | $65.83 | 2024-2025 | N/A, Evos, Pico 14 |
| Kci USA, INC. | $26.49 | 2022 | |
| Davol INC. | $17.98 | 2025 | Arista |
| Zimvie INC. | $16.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kindred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.